STOCK TITAN

Ginkgo Bioworks (NYSE: DNA) awards RSUs to 10% owner

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Canton Barry reported acquisition or exercise transactions in this Form 4 filing.

Ginkgo Bioworks Holdings, Inc. reported that ten percent owner Barry Canton received four restricted stock unit awards on July 28, 2026, covering a total of 319,332 RSUs tied to Class A Common Stock. Two grants are held directly and two indirectly via his spouse, with portions vesting 75% on October 16, 2026 and 25% on January 21, 2027, and others vesting in equal quarterly installments over 12 quarters starting October 16, 2026.

Positive

  • None.

Negative

  • None.
Insider Canton Barry
Role 10% Owner
Type Security Shares Price Value
Grant/Award Restricted Stock Units F1, F2 35,736 -- --
Grant/Award Restricted Stock Units F1, F3 117,135 -- --
Grant/Award Restricted Stock Units F1, F2 39,038 -- --
Grant/Award Restricted Stock Units F1, F3 127,423 -- --
Holdings After Transaction: Restricted Stock Units — 152,871 shares (Direct); Restricted Stock Units — 166,461 shares (Indirect, By Spouse)
Footnotes (3)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  2. F2. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.
  3. F3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.
Total RSUs granted 319,332 RSUs Combined across four awards to Barry Canton and spouse on July 28, 2026
Direct RSU grant (short-term vesting) 35,736 RSUs Vests 75% on October 16, 2026 and 25% on January 21, 2027
Direct RSU grant (12-quarter vesting) 117,135 RSUs Vests in equal quarterly installments over 12 quarters starting October 16, 2026
Indirect RSU grant by spouse (short-term vesting) 39,038 RSUs Vests 75% on October 16, 2026 and 25% on January 21, 2027
Indirect RSU grant by spouse (12-quarter vesting) 127,423 RSUs Vests in equal quarterly installments over 12 quarters starting October 16, 2026
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A Common Stock financial
"right to receive one share of the Issuer's Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
ten percent owner regulatory
"Reporting person is identified as a ten percent owner of the issuer"
Compensation Committee regulatory
"The RSUs were approved by the Compensation Committee of the Board of Directors"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity awards did Barry Canton report for Ginkgo Bioworks (DNA)?

Barry Canton reported four grants of restricted stock units totaling 319,332 RSUs, each representing one share of Class A Common Stock. The awards are split between his direct holdings and RSUs reported as held indirectly through his spouse.

How many Ginkgo Bioworks (DNA) RSUs vest on near-term dates for Barry Canton?

RSU awards totaling 74,774 RSUs vest 75% on October 16, 2026 and 25% on January 21, 2027. These vesting terms apply to both directly held and spouse-held RSUs that reference the short-term vesting footnote in the filing.

What is the long-term RSU vesting schedule for Barry Canton at Ginkgo Bioworks (DNA)?

RSU awards totaling 244,558 RSUs vest in equal quarterly installments over 12 quarters, starting on October 16, 2026. This structure spreads the equity compensation over roughly three years for both direct and spouse-held grants noted with that schedule.

Are Barry Canton's Ginkgo Bioworks (DNA) RSU grants direct or indirect holdings?

Canton received two RSU grants held directly (35,736 and 117,135 RSUs) and two held indirectly "By Spouse" (39,038 and 127,423 RSUs). All carry rights to receive Class A Common Stock upon vesting under their respective schedules.

What does each RSU reported by Barry Canton in Ginkgo Bioworks (DNA) represent?

Each restricted stock unit represents a contingent right to receive one share of Ginkgo Bioworks’ Class A Common Stock. Actual share delivery depends on the RSUs satisfying the stated vesting conditions over time.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Canton Barry

(Last)(First)(Middle)
C/O GINKGO BIOWORKS HOLDINGS
27 DRYDOCK AVENUE

(Street)
BOSTON MASSACHUSETTS 02210

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ginkgo Bioworks Holdings, Inc. [ DNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)07/28/2026A35,736 (2) (2)Class A Common Stock35,736(1)35,736D
Restricted Stock Units(1)07/28/2026A117,135 (3) (3)Class A Common Stock117,135(1)117,135D
Restricted Stock Units(1)07/28/2026A39,038 (2) (2)Class A Common Stock39,038(1)39,038IBy Spouse
Restricted Stock Units(1)07/28/2026A127,423 (3) (3)Class A Common Stock127,423(1)127,423IBy Spouse
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.
3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.
Remarks:
/s/ Karen Tepichin, Attorney-in-Fact07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)